|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330.91 USD | -0.77% |
|
+0.35% | -34.58% |
| 03/12 | Wolfe Research Adjusts PT on UnitedHealth Group to $375 From $330, Maintains Outperform Rating | MT |
| 02/12 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
| Capitalization | 300B 258B 241B 225B 416B 26,977B 452B 2,823B 1,090B 12,741B 1,125B 1,101B 46,586B | P/E ratio 2025 * |
22.1x | P/E ratio 2026 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise value | 354B 305B 285B 266B 491B 31,891B 534B 3,338B 1,289B 15,062B 1,330B 1,302B 55,073B | EV / Sales 2025 * |
0.79x | EV / Sales 2026 * | 0.77x |
| Free-Float |
99.73% | Yield 2025 * |
2.64% | Yield 2026 * | 2.74% |
Last Transcript: UnitedHealth Group Inc.
| 1 day | -0.77% | ||
| 1 week | +0.35% | ||
| Current month | +0.35% | ||
| 1 month | +2.07% | ||
| 3 months | +4.92% | ||
| 6 months | +9.13% | ||
| Current year | -34.58% |
| 1 week | 322.8 |  | 341.4 |
| 1 month | 304.53 | | 343.17 |
| Current year | 234.6 | | 606.36 |
| 1 year | 234.6 | | 606.36 |
| 3 years | 234.6 | | 630.73 |
| 5 years | 234.6 | | 630.73 |
| 10 years | 107.51 | | 630.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Hemsley
CEO | Chief Executive Officer | 72 | 12/05/2025 |
Wayne DeVeydt
DFI | Director of Finance/CFO | 55 | 02/09/2025 |
| Director of Finance/CFO | - | 01/01/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Hemsley
CHM | Chairman | 72 | 01/09/2017 |
Michele Hooper
BRD | Director/Board Member | 73 | 01/01/2007 |
Timothy Flynn
BRD | Director/Board Member | 68 | 13/01/2017 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 13.65% | 26 M€ | +11.97% | - |
| 11.3% | 135 M€ | +9.51% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.77% | +0.35% | -39.79% | -39.05% | 300B | |
| -0.31% | -2.22% | -13.45% | -37.58% | 73.51B | |
| -1.11% | -4.27% | -16.48% | -20.09% | 70.91B | |
| +1.91% | +4.92% | -8.48% | -53.05% | 31.01B | |
| -1.31% | -2.54% | -32.45% | -56.11% | 18.84B | |
| +0.86% | +2.43% | -48.52% | -55.24% | 7.81B | |
| +0.77% | +1.77% | +71.64% | +62.11% | 3.91B | |
| -0.54% | -8.91% | +62.74% | -25.54% | 2.07B | |
| -3.01% | +3.61% | -23.21% | +116.81% | 1.33B | |
| -0.17% | -1.03% | -21.87% | - | 388M | |
| Average | -0.37% | -0.70% | -6.99% | -11.97% | 50.95B | |
| Weighted average by Cap. | -0.58% | -0.48% | -29.37% | -36.69% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 448B 385B 360B 336B 620B 40,276B 675B 4,215B 1,628B 19,022B 1,680B 1,644B 69,553B | 457B 393B 368B 343B 634B 41,151B 689B 4,307B 1,663B 19,435B 1,716B 1,679B 71,062B |
| Net income | 13.63B 11.72B 10.98B 10.23B 18.9B 1,227B 20.56B 128B 49.58B 579B 51.16B 50.07B 2,119B | 14.84B 12.75B 11.95B 11.14B 20.57B 1,335B 22.37B 140B 53.96B 631B 55.68B 54.49B 2,306B |
| Net Debt | 54.6B 46.94B 43.97B 40.98B 75.7B 4,914B 82.34B 514B 199B 2,321B 205B 201B 8,486B | 52.66B 45.26B 42.4B 39.52B 73B 4,739B 79.4B 496B 192B 2,238B 198B 193B 8,184B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 330.91 $ | -0.77% | 5,905,996 |
| 04/12/25 | 333.49 $ | -1.83% | 8,061,622 |
| 03/12/25 | 339.71 $ | +4.67% | 9,769,961 |
| 02/12/25 | 324.54 $ | +0.41% | 7,978,098 |
| 01/12/25 | 323.21 $ | -1.99% | 6,154,560 |
Delayed Quote Nyse, 06 December 2025 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- UNH Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition